Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Syngenta Principal Scientist Speaks at Society of Toxicology Annual Meeting

Published: Thursday, March 22, 2012
Last Updated: Thursday, March 22, 2012
Bookmark and Share
Timothy Pastoor, Ph.D., DABT, was part of the panel presentation "Refining Your Science Communication Skills" at the meeting in San Francisco, Calif. The five-person panel gave real-world advice on communicating science, not only to other scientists but also a lay audience.

"Science, and especially toxicology, can be difficult to understand," said Pastoor. "If we, as scientists, want to be not just heard but also understood, it is vital we learn how to effectively communicate with people inside and outside our industry. This goes far beyond explaining our hypotheses, scientific methods and results to colleagues. We must be able to put data into context that is meaningful and understandable to the audience we are addressing."

Pastoor often serves as a science expert and lecturer on toxicology and risk-assessment subjects for Syngenta. Previously, he served as the company's head of Human Safety, managing a team of toxicologists and risk-assessment experts who use safety, health and environmental studies to ensure products are safe.

"Tim plays an important role on the Society's Communications Committee, and as current president of the SOT Regulatory and Safety Evaluation Specialty Section, we knew he'd be a great addition to the discussion," said Martha Lindauer, SOT Media and Communications manager. "It's great to have someone from the private sector share their expertise and perspective."

Pastoor has more than 30 years international experience in fundamental toxicity testing, mode-of-action research and human-health risk assessment. He is also a member of the Society for Risk Analysis and board member of both the Toxicology Forum and the International Life Sciences Institute/Health and Environmental Sciences Institute (ILSI/HESI).

Pastoor earned his doctorate in toxicology from the University of Michigan and is certified by the American Board of Toxicology (DABT).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos